UBMD Peds-Div of Endo/Diabetes is a clinical research site located in Buffalo, New York, United States 14203.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
UBMD Peds-Div of Endo/Diabetes has participated in 9 clinical trials with 4 currently active.
Therapeutic areas: SGA, Turner Syndrome, Noonan Syndrome, ISS, Growth Hormone Deficiency in Children, Obesity.
Sponsors: Novo Nordisk A/S.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UBMD Peds-Div of Endo/Diabetes has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UBMD Peds-Div of Endo/Diabetes has 9 clinical trials on record, with 4 currently active. Their work covers SGA, Turner Syndrome, Noonan Syndrome, ISS, Growth Hormone Deficiency in Children, Obesity.
UBMD Peds-Div of Endo/Diabetes has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.